NCT07586982 Clinical Performance of Verofilcon A Toric Contact Lenses
| NCT ID | NCT07586982 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Southern College of Optometry |
| Condition | Contact Lenses |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2026-04 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2026-04 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to \[primary purpose: is to determine if Total30 Multi focal toric conntact lensesare comfortable and the willigness for those who have previously worn reusable toric contact lenses are willing to stay in Total30 MFT after 1 month of wear during the duration of the study. Healthy previous reusable toric contact lens weareres will be refit into total30 MFT contact lenses and will be asked to gauge their comfort while wearing the lenses. Healthy adult participants who are presybyopic between the ages of 18-40 can participant, sex and gender are not disqualifiers unless the participant is pregnant or breast feeding. The main question\[s\] it aims to answer \[is/are\] \[primary hypothesis or outcome measure 1Proportions of toric CL wearers who have positive visual acuity scores in comfort and vision after one month of wear. \[primary hypothesis or outcome measure 2\]? Contact lens dry eye-8 scores will be less than 12 indicating high levels of comfort after one month of wear.
Eligibility Criteria
Inclusion Criteria: * Adults, ≥40-year-old, CL wearers with best-corrected 20/20 distance visual acuity or better. * Requiring +0.75 ADD or more at standard near distance of 40 cm. * Participants will be required to have worn reusable silicone hydrogel toric CLs in the past year and still at a minimum wearing the CLs occasionally without having significant discomfort or dryness. * All participants will be required to have a CLDEQ-8 score \<12. * Participants will be required to be able to wear Total 30MFT CLs (presbyopic plus astigmatism both ≥0.75D OD and OS). * Astigmatism ranging from 0.75 D to 2.50 D in each eye. * Participants will be required to wear the study CLs for ≥13 hours each day with no overnight wear. * Willing to wear study CLs for ≥16 hours on the Day 1 (1st full day), Day 14, and Day 29 when responses will be collected via text message. * Participants will be willing to wear the CL every day of the week. * Participants will be required to provide a glasses prescription that is less than 3 years old. * Visual acuity with habitual reusable silicone hydrogel toric CLs is 20/25 or better in each eye. Exclusion Criteria: * Have worn Total30 MFT in the past * Are past rigid CL wearers * Are currently wearing monovision CLs * Have a history of being diagnosed with dry eye or ocular allergies * Have known systemic health conditions that are thought to alter tear film physiology * Have a history of viral eye disease * Have a history of ocular surgery * Have a history of severe ocular trauma * Have a history of corneal dystrophies or degenerations * Have active ocular infection or inflammation * Are currently using isotretinoin-derivatives or ocular medications * Are pregnant or breast feeding
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07586982 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Contact Lenses. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07586982 currently recruiting?
Yes, NCT07586982 is actively recruiting participants. Contact the research team at clievens@sco.edu for enrollment information.
Where is the NCT07586982 trial being conducted?
This trial is being conducted at Memphis, United States.
Who is sponsoring the NCT07586982 clinical trial?
NCT07586982 is sponsored by Southern College of Optometry. The trial plans to enroll 32 participants.